resveratrol has been researched along with Complications of Diabetes Mellitus in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.88) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 3 (17.65) | 2.80 |
| Authors | Studies |
|---|---|
| Aboulhoda, BE; Ghoweba, RE; Khowailed, AA; Rashed, LA; Selmy, A | 1 |
| Huang, DD; Jiang, Y; Shi, G; Yao, C; Zhu, C | 1 |
| Dludla, PV; Gabuza, KB; Johnson, R; Louw, J; Mazibuko-Mbeje, SE; Mokgalaboni, K; Muller, CJF; Mxinwa, V; Nkambule, BB; Nyambuya, TM; Orlando, P; Silvestri, S; Tiano, L | 1 |
| Higashi, K; Higashi, Y; Ishii, K; Mori, A; Nakahara, T; Sakamoto, K | 1 |
| Kaczmarczyk-Sedlak, I; Mrukwa-Kominek, E; Sedlak, L; Wojnar, W; Wyględowska-Promieńska, D; Zych, M | 1 |
| Dipette, DJ; Kumar, A; Lavoie, HA; Singh, CK; Singh, US | 1 |
| Giri, PR; Joshi, PA; Majumdar, AS | 1 |
| Guo, R; Li, W; Liu, B; Wang, K; Xu, Y; Zhou, S | 1 |
| de Haan, JB; Tan, SM | 1 |
| An, R; Bai, Y | 1 |
| Elbe, H; Esrefoglu, M; Ozerol, E; Tanbek, K; Taslidere, E; Vardi, N | 1 |
| Cao, L; Chen, X; Li, W; Ma, Q; Xiao, X | 1 |
| An, R; Dang, H; Geng, T; Liang, X; Liu, Y; Ren, G; Tian, X; Yin, L | 1 |
| Hueckstaedt, LK; Li, Q; Ren, J | 1 |
| Ho, CT; Huang, D; Lv, L; Sang, S; Shao, X; Wang, L | 1 |
| Luo, Z; Ma, L; Si, L; Xu, Q; Yang, Q; Zhang, Y | 1 |
| Resmi, H | 1 |
4 review(s) available for resveratrol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications.
Topics: Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Glucose; Humans; Oxidative Stress; Resveratrol | 2020 |
Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-associated Complications: A Systematic Review of Preclinical Studies.
Topics: Animals; Antioxidants; Diabetes Complications; Dietary Supplements; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Resveratrol; Treatment Outcome | 2020 |
Diabetic complications in pregnancy: is resveratrol a solution?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Complications; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Hypoglycemic Agents; Pregnancy; Pregnancy in Diabetics; Resveratrol; Stilbenes | 2013 |
Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?
Topics: Animals; Diabetes Complications; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Leupeptins; Mice; Mice, Knockout; Molecular Targeted Therapy; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Resveratrol; Stilbenes; Sulfoxides | 2014 |
13 other study(ies) available for resveratrol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Synergistic role of resveratrol and exercise training in management of diabetic neuropathy and myopathy via SIRT1/NGF/GAP43 linkage.
Topics: Calcitonin Gene-Related Peptide; Diabetes Complications; Diabetic Neuropathies; Exercise; GAP-43 Protein; Male; Muscular Diseases; Nerve Growth Factor; Rats; Resveratrol; Sirtuin 1; Tumor Necrosis Factor-alpha | 2023 |
Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.
Topics: Aldehyde Reductase; Animals; Antioxidants; Blood Glucose; Cataract; Crystallins; Diabetes Complications; Diabetes Mellitus, Experimental; Dietary Supplements; Glucose; Hyperglycemia; Lens, Crystalline; Male; Oxidative Stress; Phytotherapy; Plant Extracts; Protein Carbonylation; Rats, Wistar; Resveratrol; Sorbitol | 2018 |
Effect of Resveratrol, a Dietary-Derived Polyphenol, on the Oxidative Stress and Polyol Pathway in the Lens of Rats with Streptozotocin-Induced Diabetes.
Topics: Animals; Antioxidants; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Diet; Glutathione; Glutathione Peroxidase; Lens, Crystalline; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Phytotherapy; Plant Extracts; Polymers; Polyphenols; Rats, Wistar; Resveratrol; Superoxide Dismutase | 2018 |
Resveratrol attenuated smokeless tobacco-induced vascular and metabolic complications in ovariectomized rats.
Topics: Animals; Aorta; Collagen; Diabetes Complications; Diabetes Mellitus; Estradiol; Female; Glucose Tolerance Test; Insulin; Metabolic Diseases; Nitrates; Nitrites; Ovariectomy; Rats; Rats, Wistar; Resveratrol; Stilbenes; Tobacco, Smokeless; Vascular Diseases | 2013 |
Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db/db mice by inhibiting the NF-κB pathway.
Topics: Animals; Antigens, Differentiation; Blood Glucose; Chemokine CCL2; Diabetes Complications; Diabetes Mellitus; Inflammation; Intercellular Adhesion Molecule-1; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Resveratrol; Signal Transduction; Stilbenes; Vascular Cell Adhesion Molecule-1 | 2014 |
Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Pressure; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Complications; Diabetes Mellitus, Experimental; Erectile Dysfunction; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Rats; Resveratrol; Second Messenger Systems; Sildenafil Citrate; Stilbenes; Sulfonamides | 2015 |
Melatonin, quercetin and resveratrol attenuates oxidative hepatocellular injury in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Biomarkers; Blood Glucose; Body Weight; Catalase; Diabetes Complications; Diabetes Mellitus, Experimental; Hepatitis; Hepatocytes; Male; Melatonin; Oxidative Stress; Quercetin; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase | 2015 |
Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
Topics: Acetylcysteine; Cell Line, Tumor; Cell Movement; Diabetes Complications; Flavonoids; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glucose; Humans; Hyperglycemia; Imidazoles; MAP Kinase Signaling System; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; Pyridines; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
Resveratrol limits diabetes-associated cognitive decline in rats by preventing oxidative stress and inflammation and modulating hippocampal structural synaptic plasticity.
Topics: Animals; Antioxidants; Blood Glucose; Cognition; Cognition Disorders; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Hippocampus; Inflammation; Male; Maze Learning; Memory; Neuronal Plasticity; Oxidative Stress; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase; Synapses | 2016 |
The protease inhibitor UCF-101 ameliorates streptozotocin-induced mouse cardiomyocyte contractile dysfunction in vitro: role of AMP-activated protein kinase.
Topics: Acetylcysteine; AMP-Activated Protein Kinases; Animals; Antioxidants; Calcium-Binding Proteins; Cardiomyopathies; Diabetes Complications; Diabetes Mellitus, Experimental; High-Temperature Requirement A Serine Peptidase 2; In Vitro Techniques; Male; MAP Kinase Signaling System; Mice; Mitochondrial Proteins; Myocardial Contraction; Myocytes, Cardiac; Protease Inhibitors; Pyrimidinones; Resveratrol; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Serine Endopeptidases; Stilbenes; Streptozocin; Thiones; X-Linked Inhibitor of Apoptosis Protein | 2009 |
Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal.
Topics: Chromatography, Liquid; Diabetes Complications; Diabetes Mellitus; Glucosides; Glycation End Products, Advanced; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Models, Molecular; Molecular Conformation; Polygonum; Pyruvaldehyde; Resveratrol; Stilbenes | 2010 |
Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation.
Topics: Adenylate Kinase; Animals; Antioxidants; Atherosclerosis; Cholesterol; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Homeostasis; Humans; Lipid Metabolism; Macrophages; PPAR gamma; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Resveratrol; Stilbenes | 2010 |
The combination of bortezomib and resveratrol may prevent muscle wasting in diabetes.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Boronic Acids; Bortezomib; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Humans; Inflammation; Models, Biological; Muscular Atrophy; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Rats; Resveratrol; Stilbenes | 2011 |